Position in BHC
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,429
-$6,356,369 QoQ
Shares Held
290
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#194
of 220 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Jun 30, 2026CallValue
$56,695
CallShares
11,500
PutValue
$23,171
PutShares
4,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $47,294,180 across 23 Drug Manufacturers - Specialty & Generic names. BHC ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
165,410 | $11,886,362 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
106,112 | $8,783,951 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
354,395 | $8,686,221 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
611,296 | $4,841,464 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
186,588 | $3,351,120 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
86,249 | $3,122,213 | |
| 7 | EOLS |
Evolus, Inc.
|
253,817 | $1,761,489 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
282,568 | $1,175,482 |
All Filings in BHC
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,429 | 290 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $23,171 | 4,700 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $56,695 | 11,500 | Call | Sole | 2026-08-03 | |
| 2026-03-31 | $6,357,798 | 1,177,370 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $5,400 | 1,000 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $66,420 | 12,300 | Call | Sole | 2026-05-13 | |
| 2025-12-31 | $8,340 | 1,200 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $161,935 | 23,300 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $96,493 | 13,884 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $647 | 100 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $1,049,259 | 162,173 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $186,218 | 23,104 | Shares | Sole | 2025-02-13 | |
| 2024-12-31 | $17,732 | 2,200 | Call | Sole | 2025-02-13 | |
| 2024-12-31 | $23,374 | 2,900 | Put | Sole | 2025-02-13 | |
| 2024-09-30 | $496,944 | 60,900 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $156,672 | 19,200 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $30,738 | 3,767 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $135,915 | 19,500 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $650,998 | 93,400 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $4,879 | 700 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $163,340 | 15,395 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $23,342 | 2,200 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $27,586 | 2,600 | Put | Sole | 2024-05-15 | |
| 2023-06-30 | $850,400 | 106,300 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $3,200 | 400 | Put | Sole | 2023-08-14 | |
| 2022-12-31 | $1,884 | 300 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $65,312 | 10,400 | Put | Sole | 2023-02-14 | |
| 2020-03-31 | $253,626 | 16,363 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $297,600 | 19,200 | Put | Sole | 2020-05-15 | |
| 2020-03-31 | $186,000 | 12,000 | Call | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||